Comorbidity Burden and Adverse Outcomes After Transcatheter Aortic Valve Replacement

Background Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for symptomatic patients with aortic stenosis and elevated procedural risk. Many deaths following TAVR are because of noncardiac causes and comorbid disease burden may be a major determinant of postprocedure...

Full description

Bibliographic Details
Main Authors: Daniel R. Feldman, Mikhail D. Romashko, Benjamin Koethe, Sonika Patel, Hassan Rastegar, Yong Zhan, Charles D. Resor, Annie C. Connors, Carey Kimmelstiel, David Allen, Andrew R. Weintraub, Benjamin S. Wessler
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.018978